Skip to main content

Table 4 Diagnostic efficacy of ADC-pre, MD-pre, MK-pre, Dslow-pre and PRE

From: Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy

 

AUC

95%CI

Youden

Cutoff

sensitivity

specificity

+LR

-LR

+PV

-PV

ADC-pre

(×10−6 mm2/s)

0.885

(0.772,0.955)

0.650

1210

75.00%

90.00%

7.50

0.28

93.1

66.7

MD-pre

(×10−6 mm2/s)

0.855

(0.735,0.935)

0.556

1010

80.6%

75.0%

3.22

0.26

85.3

68.2

MK-pre

(×10−6)

0.692

(0.555,0.809)

0.394

832

94.4%

45.0%

1.72

0.12

75.6

81.8

Dslow-pre

(×10−6 mm2/s)

0.742

(0.608,0.850)

0.450

835

75.00%

70.00%

2.50

0.36

81.8

60.9

PRE

0.912

(0.806,0.971)

0.672

0.799

72.22%

95.00

14.44

0.29

96.3

65.5

  1. Abbreviation: AUC: area under the curve; 95% CI: 95% confidence interval; +LR: positive likelihood ratio; −LR: negative likelihood ratio; +PV: positive predictive value; −PV: negative predictive value